Impact of cethromycin (ABT-773) therapy on microbiological, histologic, immunologic, and respiratory indices in a murine model of Mycoplasma pneumoniae lower respiratory infection.

Impact of cethromycin (ABT-773) therapy on microbiological, histologic, immunologic, and respiratory indices in a murine model of Mycoplasma pneumoniae lower respiratory infection.

Item
http://www.wikidata.org/entity/Q34335695
A lyophilized formulation of RiVax, a recombinant ricin subunit vaccine, retains immunogenicity.Microbiologic and immunologic evaluation of a single high dose of azithromycin for treatment of experimental Mycoplasma pneumoniae pneumoniaEvaluation of LBM415 (NVP PDF-713), a novel peptide deformylase inhibitor, for treatment of experimental Mycoplasma pneumoniae pneumoniaComparative effects of two neutralizing anti-respiratory syncytial virus (RSV) monoclonal antibodies in the RSV murine model: time versus potency.Mycoplasma pneumoniae and its role in asthmaEfficacy of increasing dosages of clarithromycin for treatment of experimental Mycoplasma pneumoniae pneumonia.Cethromycin-mediated protection against the plague pathogen Yersinia pestis in a rat model of infection and comparison with levofloxacinRespiratory syncytial virus persistence in the lungs correlates with airway hyperreactivity in the mouse model.Advances in MRSA drug discovery: where are we and where do we need to be?Tigecycline therapy significantly reduces the concentrations of inflammatory pulmonary cytokines and chemokines in a murine model of Mycoplasma pneumoniae pneumonia.Cethromycin: a promising new ketolide antibiotic for respiratory infections.Advances in the prevention, management, and treatment of community-acquired pneumoniaImmunomodulatory effects of macrolides during community-acquired pneumonia: a literature review.Antibiotics in development targeting protein synthesis.Treatment with anti-inflammatory drugs in community-acquired pneumonia.RiVax, a recombinant ricin subunit vaccine, protects mice against ricin delivered by gavage or aerosolMacrolide Use and Neutrophil Function/Cytokine Levels in Hospitalized Patients with Community-Acquired Pneumonia: A Pilot Study.
P2860

Impact of cethromycin (ABT-773) therapy on microbiological, histologic, immunologic, and respiratory indices in a murine model of Mycoplasma pneumoniae lower respiratory infection.

Item
http://www.wikidata.org/entity/Q34335695
description
2004 nî lūn-bûn
@nan
2004 թուականի Օգոստոսին հրատարակուած գիտական յօդուած
@hyw
2004 թվականի օգոստոսին հրատարակված գիտական հոդված
@hy
2004年の論文
@ja
2004年論文
@yue
2004年論文
@zh-hant
2004年論文
@zh-hk
2004年論文
@zh-mo
2004年論文
@zh-tw
2004年论文
@wuu
name
Impact of cethromycin (ABT-773 ...... e lower respiratory infection.
@ast
Impact of cethromycin (ABT-773 ...... e lower respiratory infection.
@en
Impact of cethromycin (ABT-773 ...... e lower respiratory infection.
@nl
type
label
Impact of cethromycin (ABT-773 ...... e lower respiratory infection.
@ast
Impact of cethromycin (ABT-773 ...... e lower respiratory infection.
@en
Impact of cethromycin (ABT-773 ...... e lower respiratory infection.
@nl
prefLabel
Impact of cethromycin (ABT-773 ...... e lower respiratory infection.
@ast
Impact of cethromycin (ABT-773 ...... e lower respiratory infection.
@en
Impact of cethromycin (ABT-773 ...... e lower respiratory infection.
@nl
P1433
P1476
P2093
P2860
P304
P31
P356
P407
P433
P478
P50
P577
P698
P932
P356
P1433
P1476
Impact of cethromycin (ABT-773 ...... e lower respiratory infection.
@en
P2093
P2860
P304
P31
P356
10.1128/AAC.48.8.2897-2904.2004
P407
P433
P478
P50
P577
P698
P932